GLG News by Physicians who Treat Peripheral Vascular Disease

This article deals with standards for those companies harvesting and storing stem cells for sale to research firms and other medical researchers and universities. These regulations are a good step to insuring the reliability of these cells and the validity of the subsequent research. This...

ProRhythm's HIFU Ablation system is a balloon catheter devised for minimally invasive treatment of atrial fibrillation.Atrial fibrillation is a heart rhythm disorder where the atria (collecting chambers of the heart) do not contract properly.This disorder affects millions of patients and leads to a...

Prophylactic antibiotics are prescribed to prevent infection during a "clean" surgical case.The ideal prophylaxis will be available in the tissues at the time the skin incision is made and will be effective against the most likely organisms at the surgical site.This study demonstrates that a single...

COPD is also a major health problem in the US.Tobacco abuse contributes heavily to COPD as well as to CAD.This study shows the Pleiotropic properties of statins (primarily simvastatin) significantly reduce the age related deterioration in lung function (as measured by FEV1) in smokers taking statins...

To date, there have been no randomized clinical trials that look at all the variables to determine the optimal LDL-C level which should be the treatment goal.Trials such as the PROVE IT trial mentioned in this article and others such as TNT (treating to new targets) propound the theory that lower is...

This article describes an association between Parkinson's disease and low LDL cholesterol levels.Researchers at the University of North Carolina found that patients with low levels of LDL cholesterol are upward of three and a half times more likely to develop Parkinson’s disease than those with higher...

Acomplia (Rimonabant) is a novel selective CB1 endocannibinoid receptor antagonist that was developed as an anti-obesity drug to promote weight loss.This drug is not a stimulant - it works on receptors in the brain responsible for the desire to eat.In clinical trials, rimonabant has been shown...

The PROMUS everolimus eluting stent system has been launched in Europe.This represents the 2nd drug eluting stent from Boston Scientific (in conjunction with Abbott).  PROMUS is a private-labeled XIENCE™ V Everolimus Eluting Coronary Stent System manufactured by Abbott and distributed by...

Lilly recently halted the Phase II trial of its PPAR - alpha agent LY674 because of the appearance of fatty liver deposits seen in a preclinical trial with primates.While concerning, this does not mean this product is doomed - only that the trials may need to be modified to assess the patients for any...

Peripheral arterial disease is a widespread but underdiagnosed and undertreated problem in the industrialized nations.It frequently co-exists with coronary artery disease and cerebrovascular disease and it a major cause of morbidity. The causes include hypertension, dyslipidemias, diabetes, renal failure,...